Meet Our Featured Speakers

benefits

Orphan Drug Summit 2026 provides market insights and industry updates on the latest advancements in rare disease management, drug development, and manufacturing processes.

Benefits of attending include:

Two days of in-depth presentations showcasing the latest market intelligence and addressing key areas of focus in the pharmaceutical industry through shared results and experiences in orphan drug development and rare disease therapeutics.
An exclusive networking opportunity to connect with professionals who share similar challenges and experiences in the rapidly evolving orphan drug and rare medicine sector.
Updates on ongoing projects and research led by orphan drug experts and manufacturers, highlighting their experiences, findings, and new proposals in rare disease therapies.
Technical presentations from orphan drug developers highlighting the latest results from recent tests and trials, technological advancements, and emerging technical expertise.
New case studies from leading clinical trials featuring specific examples of orphan drug development initiatives in rare disease therapeutics.
A unique opportunity to connect with a wide range of manufacturers and explore new market opportunities by gaining insights into the evolving orphan drug and rare medicine sector.

key takeaways

Understand the current market dynamics shaping orphan drug development and rare disease therapeutics
Learn how to build effective strategies for formulations and delivery systems used in rare disease treatments
Hear about the latest trends and projections in orphan drug synthesis and manufacturing processes
Discuss innovations and technological developments across a range of rare disease therapies
Access insights from a wide range of experts and related industries, each bringing unique experiences

who should attend?

This event is aimed at leading pharmaceutical companies, drug developers, researchers, clinical trial coordinators, and healthcare industry professionals interested in learning about orphan drug applications for managing rare diseases.

Core attendees include CEOs, COOs, CFOs, Presidents, Vice Presidents, Directors, Heads of, Superintendents, and Managers involved in:

Drug Development Experts Drug Manufacturing Business Development Pharmaceutical Technologists Formulation Experts Clinical Trials and Approvals Drug Discovery Researchers Clinical Trials Manufacturing Research & Innovation Biotherapeutics & Biologics Clinical Diagnostics Research and Development Biotechnology Researchers Companion Diagnostics Strategy, Projects, & Public Policy Nanotechnologies Genetic Medicine Experts Sales and Marketing Initiatives Nano & Micro Robotics System Biology and Research Legal and Regulatory Modalities Research Precision Medicines Equipment Certification Services Molecular Medicine Laboratory Equipments News Reporting and Journalism

they've attended our events

Namrita Negi

Deloitte

"In-depth, highly relevant discussions of key challenges in the rare disease community."

Barry Weber

Global Genes

"Gained valuable insights into diverse functions across the research and biotech industry."

Evan Ingersoll

Backstop/Catalyst LLC

"The event delivered focused and highly relevant communications and updates."

Gaelle Mercenne

Talus Bio

"Strong talks, an inclusive audience, and a dynamic meeting overall."

Gulen Tonga

Tessera Therapeutics

"This summit broadened my understanding and helped me connect with diverse stakeholders."

Jill Goodrich

Dent Disease Foundation

"A unique exchange among community members in the rare disease space."

SUBSCRIBE FOR UPDATES

By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.